catalyst
as of 2026-07-01A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negat — primary completion
at a glance
2014-07 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.
Event
What
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negat — primary completion
Type
Trial Readout
Date
2014-07
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here